Visual and High-Efficiency Secretion of SARS-CoV-2 Nanobodies with <i>Escherichia coli</i>
Nanobodies have gained attention as potential therapeutic and diagnostic agents for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) due to their ability to bind and neutralize the virus. However, rapid, scalable, and robust production of nanobodies for SARS-CoV-2 remains a crucial chall...
Saved in:
Main Authors: | Shuai Zhao, Wanting Zeng, Fang Yu, Pingping Xu, Chin-Yu Chen, Wanping Chen, Yanming Dong, Fei Wang, Lixin Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/15/1/111 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GB18-06, a nanobody targeting GDF15, effectively alleviates weight loss and restores physical function in cachexia models
by: Yu Huang, et al.
Published: (2024-12-01) -
Applications and challenges in designing VHH-based bispecific antibodies: leveraging machine learning solutions
by: Michael Mullin, et al.
Published: (2024-12-01) -
The potential role of nanobodies in asthma therapy
by: Baraa Khalid Salah Al-Sheakly, et al.
Published: (2025-01-01) -
Development of chimeric Nanobody-Granzyme B functionalized ferritin nanoparticles for precise tumor therapy
by: Baijin Xia, et al.
Published: (2025-03-01) -
A HER2 Specific Nanobody–Drug Conjugate: Site-Selective Bioconjugation and In Vitro Evaluation in Breast Cancer Models
by: Anders H. Hansen, et al.
Published: (2025-01-01)